ADMA — ADMA BIOLOGICS INC

Ownership history in CITIGROUP INC · 33 quarters on record

This page tracks every 13F SEC filing in which CITIGROUP INC reported a position in ADMA BIOLOGICS INC (ADMA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

0.01% (2025 Q1)

Avg. % of fund

0.0%

First filed

2015 Q3

Last filed

2025 Q4

Quarters held

33

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q4	ADDED	102,986	+52,386	+103.5%	0.00%	$1.9M	$18.24
2025 Q3	REDUCED	50,600	-469,859	-90.3%	0.00%	$742K	$14.66
2025 Q3	ADDED	520,459	+469,859	+928.6%	0.00%	$7.6M	$14.66
2025 Q2	REDUCED	50,600	-683,186	-93.1%	0.00%	$921K	$18.21

% of Fund (quarterly) ADMA price (monthly, adj. close)

Other funds also holding ADMA

As of 2025 Q4 — sorted by position size

B Group, Inc. 33.1% Stonepine Capital Management, LLC 3Y 7Y 9.85% Sachem Head Capital Management LP 3Y 7Y 4.86% Caligan Partners LP 3Y 4.52% AWM Investment Company, Inc. 3Y 7Y 3.87% Ranger Investment Management, L.P. 3Y 7Y 2.88% PFM Health Sciences, LP 3Y 7Y 2.31% MARATHON CAPITAL MANAGEMENT 3Y 7Y 1.83% Catalio Capital Management, LP 1.82% FINDELL CAPITAL MANAGEMENT LLC 1.57%

← Back to CITIGROUP INC Holdings